pharma news today obesity drugs glp-1 september 2025 medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended during pregnancy or while nursing. The current recommendation is to stop before conception and discuss A network meta-analysis backed weight-loss

Ocular hypertension triggers the production of pro-inflammatory cytokines by immune cells, which in turn drives the transformation of neuroprotective astrocytes into a neurotoxic A1-reactive phenotype, ultimately leading to RGC degeneration [45]

Niacinamide Niacinamide creates the optimal pH environment for hair growth while reducing the scalp inflammation that's been damaging your follicles

These medications affect weight loss through multiple mechanisms: Appetite Regulation: GLP-1 medications interact with brain receptors that control hunger signals, helping reduce food cravings and overall calorie intake Blood Sugar Management: These medications improve blood sugar levels by enhancing insulin secretion when blood glucose is elevated Gastric Emptying: GLP-1 medications slow the movement of food from the stomach to the small intestine, promoting feelings of fullness Metabolic Effects: These drugs can influence metabolic rate and fat storage patterns in ways that support sustainable weight loss These combined effects can lead to significant weight reduction when used as part of a comprehensive treatment plan that includes lifestyle modifications

Protein & Macronutrient Blends Dominate Product Preference The protein & macronutrient blends segment held a 39.4% share in 2024 and is projected to reach 43% in 2025

"Morning is the only way to go." "Evening changed my life." "Friday injection is the best." And they are all correct, for themselves

After that point, the refund window closes